Dyslipidemia and
obesity are emerging as a major public health challenge in South Asian
countries. The prevalence of obesity is more in urban areas than rural. There
is greater accumulation of fat at “ectopic” sites, namely the liver and the
skeletal muscles. This feature leads to higher magnitude of insulin resistance,
and its concomitant metabolic disorders (the metabolic syndrome) including
atherogenic dyslipidemia.
 |
| Dyslipidemia |
Metabolic Syndrome (MetS) is a plausible precondition
for type II diabetes and Cardiovascular Diseases (CVD). MetS is characterised
by symptoms of obesity, insulin resistance, hypertension, dyslipidemia and
diabetes mellitus. The pathophysiological mechanisms involved in MetS are
complex and involved dysregulation of many biochemical and physiological
regulatory mechanisms of the body. Read More>>>>>>>>
No comments:
Post a Comment